Patents for A61P 27 - Drugs for disorders of the senses (53,017)
04/2012
04/11/2012CN102413832A Method of reducing intraocular pressure in humans
04/11/2012CN102408975A Health care sake
04/11/2012CN102408411A Hydroximic acid compound containing quinolyl and preparation method thereof, and drug composition containing the compound and use thereof
04/11/2012CN102406934A 一种鸡传染性鼻炎类脂灭活疫苗的制备方法 Preparation method of infectious coryza lipid inactivated vaccine
04/11/2012CN102406845A 一种治疗角膜溃疡的中药组合物 A method of treating corneal ulcer medicine composition
04/11/2012CN102406751A 一种治疗黄风内障的中药组合物 A yellow wind barrier treatment of traditional Chinese medicine composition
04/11/2012CN102406750A 一种治疗暴风客热的中药组合物 A method of treating storm off the hot herbal composition
04/11/2012CN102406728A Medicinal composition for treating lymphaden inflammations
04/11/2012CN102406692A 治疗口腔白塞氏病的中药组合物及其制法 Behcet's disease treatment of oral Chinese medicine composition and its preparation method
04/11/2012CN102405935A 鱼精蛋白复配制剂及其制备方法和应用 Protamine complex and its preparation method and application
04/11/2012CN101716200B 一种活血通脉、清热解毒的药物组合物及其制备方法和应用 One kind Huoxuetongmai, detoxification of the pharmaceutical composition and its preparation method and application
04/11/2012CN101199659B 一种治疗急性结膜炎的内服中药 A method of treating acute conjunctivitis internal medicine
04/10/2012US8153806 Synthesis of 4-amino-thalidomide enantiomers
04/10/2012US8153673 Metalloproteinase inhibitors
04/10/2012CA2660167C Compositions and methods for treating, reducing, ameliorating, or alleviating posterior-segment ophthalmic diseases
04/10/2012CA2486663C Method of treating rosacea by topical application of a cyclohexane derivative
04/10/2012CA2477241C Compositions and methods for treating epithelial and retinal tissue diseases
04/10/2012CA2445408C Quinolone carboxylic acid compositions and related methods of treatment
04/05/2012WO2012043891A1 Agent for treatment of eye diseases
04/05/2012WO2012043185A1 Composition for inhibiting il-8 expression
04/05/2012WO2012024419A3 Bradykinin receptor agonists and uses thereof to treat ocular hypertension and glaucoma
04/05/2012US20120083772 Corneal treatment system and method
04/05/2012US20120083502 Heterocyclic compounds and their uses
04/05/2012US20120083479 Compositions Comprising Azelastine and Methods of Use Thereof
04/05/2012US20120083476 Heteroaryl-substituted spirocyclic diamine urea modulators of fatty acid amide hydrolase
04/05/2012US20120083474 Heterocyclic amides as modulators of trpa1
04/05/2012US20120082686 Neovascular-Targeted Immunoconjugates
04/05/2012US20120082635 2-amino-2- [8-(dimethyl carbamoyl)- 8-aza- bicyclo [3.2.1] oct-3-yl]-exo- ethanoyl derivatives as potent dpp-iv inhibitors
04/05/2012US20120082627 Otic foam formulations
04/04/2012EP2436675A1 Novel -phenoxybenzeneacetic acid derivative and pharmaceutical preparation comprising same
04/04/2012EP2435412A1 Disaccharin, difumaric acid, di-l-hydroxy-2-naphthoic acid and mono-benzoic acid salts of 4- (dimethylamin0)butyl 2- (4- ( (2-amino-4-methyl-6- (pentylamino) pyrimidin- 5 -yl) methyl) phenyl)acetate
04/04/2012EP2435075A2 Antigen-binding proteins
04/04/2012EP1990343B1 Azaindoles
04/04/2012EP1778619B1 T type calcium channel inhibitors
04/04/2012CN1602199B Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation
04/04/2012CN102397463A 一种用中草药治疗眼疾玻璃体混浊的方法 An eye vitreous opacities with herbal treatment methods
04/04/2012CN102397429A 一种治疗白内障的中药组合物 A method of treating cataract herbal composition
04/04/2012CN102397384A 一种鱼腥草滴眼液及其制备方法 One kind of eye drops and its preparation method Yuxingcao
04/04/2012CN102396935A 一种保健柳丝草席 A health Stir mats
04/04/2012CN101675939B 一种治疗眼角膜炎的中药滴眼液 A method of treating ocular keratitis medicine drops
04/04/2012CN101669901B 用于眼部给药的液体制剂及其制备方法 Liquid and its preparation method for ocular administration
04/03/2012US8148525 2,4-pyrimidinediamine compounds and their uses
04/03/2012US8148429 Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands
04/03/2012US8148125 Human aminoacyl-tRNA synthetase polypeptides useful for the regulation of angiogenesis
04/03/2012CA2582316C Use of inhibitors of jun n-terminal kinases for the treatment of glaucomatous retinopathy and ocular diseases
04/03/2012CA2467759C Use of nanoparticles as carriers for biocides in ophthalmic compositions
03/2012
03/29/2012WO2012038512A2 Composition comprising sod, lutein and zeaxanthin
03/29/2012WO2012037782A1 Tricyclic compounds, preparation methods, and their uses
03/29/2012US20120077883 Treatment of tinnitus and associated auditory dysfunctions
03/29/2012US20120077870 Materials and Methods for the Treatment of Pathological Neovascularization in the Eye
03/29/2012US20120077864 Rnai-mediated inhibition of gremlin for treatment of iop-related conditions
03/29/2012US20120077857 Inhibition of inflammation bysimultaneous blockade of multiple prostanoid receptors
03/29/2012US20120077854 Compositions and methods for modulating retinol binding to retinol binding protein 4 (rbp4)
03/29/2012US20120077840 Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors
03/29/2012US20120077830 Caspase inhibitors and uses thereof
03/29/2012US20120077828 Chemical compounds
03/29/2012US20120077826 [6,5] - bicyclic gpr119 g protein-coupled receptor agonists
03/29/2012US20120077815 Fused Pyridine And Pyrazine Derivatives As Kinase Inhibitors
03/29/2012US20120077787 Organic compounds
03/29/2012US20120077769 Topical ophthalmic compositions containing tobramycin and dexamethasone
03/29/2012US20120077763 METHODS FOR TREATING HEART FAILURE BY INHIBITING THE MITOCHONDRIAL SODIUM-CALCIUM EXCHANGER (mNCE)
03/29/2012US20120077756 Methods, compositions, and kits for the treatment of ophthalmic disorders
03/29/2012US20120076848 Method and system for effecting changes in pigmented tissue
03/29/2012US20120076787 Combination of a tnf-alpha antagonist and a vegf antagonist for use in the treatment or prevention of diseases of the eye
03/29/2012CA2812999A1 Composition comprising sod, lutein and zeaxanthin
03/28/2012EP2432475A1 A3 adenosine receptor agonists for the reduction of intraocular pressure
03/28/2012EP2432472A1 3-[4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl]octane- or heptane-nitrile as jak inhibitors
03/28/2012EP2186529B1 Synergic pharmaceutical composition, useful for inhibiting corneal and retinal neovascularization (angiogenesis), and in other organs, in a human being or animal
03/28/2012EP1472234B1 Quinazolinone derivatives and their use as cb agonists
03/28/2012EP1432707B1 Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease
03/28/2012CN102395589A Fused pyrrolopyridine derivative
03/28/2012CN102395401A Drug delivery through hydrogel plugs
03/28/2012CN102395364A Pharmaceutical compositions
03/28/2012CN102391095A Rheum emodin derivative and application thereof
03/28/2012CN102389500A Heat clearing and detoxifying oral solution
03/28/2012CN102389488A Traditional Chinese medicine for curing diabetic retinopathy
03/28/2012CN102389433A Pharmaceutical composition and compound preparation thereof
03/28/2012CN102389412A Eye drops for treating cataract
03/28/2012CN102389411A Application of gallic acid to preparation of phosphodiesterase inhibitor anti inflammatory medicine
03/28/2012CN102389392A Recombinant bovine basic fibroblast growth factor gel for eye use
03/28/2012CN102389234A Myrica rubra kernel health care mattress
03/28/2012CN102028757B Processing method of mulberry composite extract
03/28/2012CN102018736B Natural indigo decoction piece and preparation method thereof
03/28/2012CN101797348B Traditional Chinese medicine for treating proliferative vitreoretinopathy
03/28/2012CN101747425B Protein relevant to retina photoreaction as well as coding gene and applications thereof
03/28/2012CN101537087B Traditional Chinese medicine composition for treating retinal vein obstruction
03/27/2012US8143312 Transparent eye drops containing latanoprost
03/27/2012US8143291 Indole compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (S1P) receptor biological activity
03/27/2012CA2606370C Self-preserved aqueous pharmaceutical compositions
03/27/2012CA2489862C Epimerized derivatives of k5 polysaccharide with a very high degree of sulfation
03/27/2012CA2329250C Peptide antiangiogenic drugs
03/22/2012WO2012037499A1 Ester pro-drugs of [3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl] methanol
03/22/2012WO2012037490A1 Ester pro-drugs of [3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl] methanol for lowering intraocular pressure
03/22/2012WO2012037453A1 Ester pro-drugs of [3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl] methanol for treating retinal diseases
03/22/2012US20120071865 Flowable hydrogels for control of cell in-migration
03/22/2012US20120071558 Compositions of very long chain polyunsaturated fatty acids and methods of use
03/22/2012US20120071550 Synergistic combinations of cartonoids and polyphenols
03/22/2012US20120071542 Application of Highly Conserved Domain Sequences From Viral Genome As Template To Design Therapeutic Slirnas
03/22/2012US20120071534 Lxr modulators
03/22/2012US20120071529 Tetrazole Compounds Which Selectively Modulate The CB2 Receptor
1 ... 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 ... 531